P
Pharmaceutics International
Multinational contract formulation development, clinical trial materials, and commercial manufacturing company
About Pharmaceutics International
Pharmaceutics International, Inc. (Pii) is a contract development and manufacturing organization (CDMO) that provides comprehensive services for the pharmaceutical industry. With over 25 years of experience, Pii specializes in the development and cGMP (current Good Manufacturing Practice) manufacturing of liquid, suspension, and lyophilized parenterals, as well as oral liquids, suspensions, and solid dosage forms. The company serves a diverse range of clients, including pharmaceutical and biotechnology companies, offering tailored solutions to meet unique project needs.
Pii operates in the highly regulated pharmaceutical market, focusing on parenteral drug development and injectable processing. The company's business model revolves around providing end-to-end solutions, from early-stage development to commercial manufacturing. Pii generates revenue through service contracts, offering expertise in areas such as dosage form formulation, aseptic filling, lyophilization, clinical trial manufacturing, and commercial manufacturing.
The company is committed to transparency, dedication, and integrity, ensuring that every partnership is built on trust and mutual success. Pii also offers specialized services like high potent HPAPI (Highly Potent Active Pharmaceutical Ingredients) handling, cytotoxic drug processing, and DEA Schedule I-V controlled substances management. Additionally, Pii provides regulatory support, analytical quality assurance, and serialization equipment to ensure compliance with industry standards.
Pii's recent expansion in sterile manufacturing operations aims to deliver high-quality, small and medium batch aseptic fill finish efficiently and on accelerated timelines. The company also offers a $100,000 grant for First in Human Project Funding, encouraging innovation in therapeutic development.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1994
- Headquarters
- Cockeysville, United States
- Employees
- 354
- Open positions
- 35
- Dealroom signal
- 66.4/100
- Industry
- Health, Legal
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Feb 2025 | $0 | — | Jabil | ↗ |
| LATE VCOther financing | Jun 2023 | $6M | $50M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Pharmaceutics International is 3.4K monthly website visits, down 5.6% over the last three months. Pharmaceutics International's team declined 0.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Pharmaceutics International in the Cockeysville ecosystem
The Pharmaceutics International office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Jabil
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pharmaceutics International on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pharmaceutics International’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









